Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Erhardt

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Neuroscience Letters|March 16, 2000
Quantitative changes in interleukin proteins following focal stroke in the ratJ J Legos, R G Whitmore, J A Erhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosisB McLaughlin, S Pal, M P Tran, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 19, 2000
The novel beta-blocker, carvedilol, provides neuroprotection in transient focal strokeS I Savitz, J A Erhardt, J V Anthony, et al.
Brain Research|February 15, 2001
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemiaJ J Legos, J A Erhardt, R F White, et al.
Journal of Thrombosis and Haemostasis : JTH|September 12, 2006
A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosisJ R Toomey, M A Abboud, R E Valocik, et al.
Medicinal Research Reviews|February 27, 2001
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neuroscience Letters|March 16, 2000
Quantitative changes in interleukin proteins following focal stroke in the ratJ J Legos, R G Whitmore, J A Erhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosisB McLaughlin, S Pal, M P Tran, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 19, 2000
The novel beta-blocker, carvedilol, provides neuroprotection in transient focal strokeS I Savitz, J A Erhardt, J V Anthony, et al.
Brain Research|February 15, 2001
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemiaJ J Legos, J A Erhardt, R F White, et al.
Journal of Thrombosis and Haemostasis : JTH|September 12, 2006
A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosisJ R Toomey, M A Abboud, R E Valocik, et al.
Medicinal Research Reviews|February 27, 2001
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemiaF C Barone, E A Irving, A M Ray, et al.
Pageof 2